® Receives US OMRI Listing for Use in Organic Cattle Production

NovaVive Inc.

NovaVive is a private Canadian immunobiology company founded in July, 2014. The Company acquired an advanced veterinary immunotherapeutic platform based on mycobacterium cell wall fraction (MCWF) technology with regulator-approved products for cattle, horses and dogs. These products are currently sold to veterinarians in the U.S.A., Canada, Australia and New Zealand. The Company's head office is located in Napanee, Ontario, Canada.

Sign up to stay up-to-date with NovaVive news.

Recent News

Amplimune® Receives US OMRI Listing for Use in Organic Cattle Production

Amplimune®, our immunotherapeutic for calf scours, has received an Organic Materials Review Institute (OMRI) Listing in the U.S.A. This means that Amplimune can be used in compliance with the USDA National Organic Program.

learn more

NovaVive Inc. Hires a Senior Vice-President, U.S. Sales & Marketing

NovaVive is pleased to welcome Robert (Bob) Barclay as Senior Vice-President, U.S. Sales & Marketing effective January 1, 2018. Bob has several years of experience in animal health, including 11 years with Zoetis Inc.

learn more

Iowa State University College of Veterinary Medicine to Conduct a Study with Immunocidin® Equine in Two Types of Cancer

NovaVive's Immunocidin® Equine anticancer immunotherapeutic for horses will be evaluated in a clinical study at Iowa State University (ISU) College of Veterinary Medicine in sarcoids and squamous cell carcinoma.

learn more

Follow NovaVive on Social Media.